CTT Pharmaceutical Holdings, Inc. engages in the development of drug delivery systems technology within the pharmaceutical industry. The company is headquartered in Tampa, Florida. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The company rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. The company offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. The company is a thin film for treating dogs and cats.
CTTH stock price ended at $0.06 on 木曜日, after dropping 14.29%
On the latest trading day Aug 06, 2026, the stock price of CTTH fell by 14.29%, dropping from $0.06 to $0.06. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.06 and a high of $0.06. On the latest trading day, the trading volume for CTTH decreased by 36.5K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.6K shares were traded, with a market value of approximately $3.5M.